Skip to main navigation Skip to search Skip to main content

Hyperlipidemia in kidney disease: Causes and consequences

  • Meena Sahadevan
  • , Bertram L. Kasiske

Research output: Contribution to journal › Review article › peer-review

Abstract

Dyslipidemias are common in patients with chronic kidney disease. The causes vary with the stage of kidney disease, the degree of proteinuria, and the modality of end-stage renal disease treatment. Dyslipidemias have been associated with kidney disease progression, and a number of small, randomized, controlled trials of lipid-lowering agents have been conducted. Unfortunately, the results of these trials, although encouraging, have been inconclusive because of the small numbers of patients enrolled. Dyslipidemias may also contribute to the high incidence of cardiovascular disease in patients with chronic kidney disease. This is most likely for patients with chronic renal insufficiency and for kidney transplant recipients. Less certain is the role of dyslipidemias in the pathogenesis of cardiovascular disease among dialysis patients.

Original languageEnglish (US)
Pages (from-to)323-329
Number of pages7
JournalCurrent opinion in nephrology and hypertension
Volume11
Issue number3
DOIs
StatePublished - May 21 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Hyperlipidemia in kidney disease: Causes and consequences'. Together they form a unique fingerprint.

Cite this